Recruiting × Uterine Cervical Neoplasms × 30 days × Clear all A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors
Phase 2 Recruiting
190 enrolled
mNav
Phase NA Recruiting
288 enrolled
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Phase 2 Recruiting
25 enrolled
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Phase 1 Recruiting
63 enrolled
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Phase 1 Recruiting
1,006 enrolled
NEXUS-01
Phase 1 Recruiting
420 enrolled
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Phase 4 Recruiting
100 enrolled
ECHO
Recruiting
3,110 enrolled
PAROLA
Phase 3 Recruiting
510 enrolled
TroFuse-020
Phase 3 Recruiting
686 enrolled
TroFuse-036
Phase 3 Recruiting
1,023 enrolled
PSI-Immune
Phase 2 Recruiting
880 enrolled
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
76 enrolled
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
450 enrolled
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Phase 1/2 Recruiting
350 enrolled
INDIGO
Phase NA Recruiting
11,200 enrolled
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
949 enrolled
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
Phase 1 Recruiting
70 enrolled
panSOHO
Phase 2 Recruiting
111 enrolled
STEALTH-001
Phase 1 Recruiting
60 enrolled
A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer
Phase 3 Recruiting
398 enrolled
HPV-Vac-S
Recruiting
5,500 enrolled
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Phase NA Recruiting
400 enrolled
Pap
Phase NA Recruiting
250 enrolled
DP-04
Recruiting
100 enrolled
RAD301
Phase 1 Recruiting
9 enrolled
Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana
Phase NA Recruiting
610 enrolled
SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer
Phase 2 Recruiting
89 enrolled
AppDate-You
Phase NA Recruiting
3,000 enrolled
MOTTO
Phase NA Recruiting
524 enrolled
BetaBart
Phase 1/2 Recruiting
61 enrolled
HypoRTCx-UG
Phase 2 Recruiting
278 enrolled
A Study of Ivonescimab in People With Endometrial and Cervical Cancers
Phase 2 Recruiting
50 enrolled
HART
Recruiting
120 enrolled